Improved survival and antagonistic effect of sodium fusidate on tumor necrosis factor alpha in a neonatal mouse model of endotoxin shock

Antimicrobial Agents and Chemotherapy

Volumn 40, Issue 7, 1996, Pages 1733-1735

  Genovese, Francesco ^a   Mancuso, Giuseppe ^a   Cuzzola, Maria ^a   Cusumano, Vitaliano ^a   Nicoletti, Ferdinando ^b   Bendtzen, Klaus ^c   Teti, Giuseppe ^a  

^a UNIVERSITY OF MESSINA   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

^c Rigshospitalet   (Denmark)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; ERYTHROMYCIN; FUSIDATE SODIUM; PENICILLIN G SODIUM; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG ANTAGONISM; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; SALMONELLA ENTERITIDIS; SEPSIS; SEPTIC SHOCK; SURVIVAL RATE;

EID: 0029948880     PISSN: 00664804     EISSN: None     Source Type: Journal    
DOI: 10.1128/aac.40.7.1733     Document Type: Article

References (29)

1. Beal, A. L., and F. B. Cerra. 1994. Multiple organ failure syndrome in the 1990s. Systemic inflammatory response and organ dysfunction. JAMA 271: 226-233.
2. Bendtzen, K. 1988. Interleukin 1, interleukin 6 and tumor necrosis factor in infection, inflammation and immunity. Immunol. Lett. 19:183-192.
3. Bendtzen, K., M. Diamant, and V. Faber. 1990. Fusidic acid, an immunosuppressive drug with functions similar to cyclosporin A. Cytokine 2:423-429.
4. Car, B. D., V. M. Eng, B. Schnyder, L. Ozmen, S. Huang, P. Gallay, D. Heumann, M. Aguet, and B. Ryffel. 1994. Interferon γ receptor deficient mice are resistant to endotoxic shock. J. Exp. Med. 179:1437-1444.
5. Cerami, A. 1993. Tumor necrosis factor as a mediator of shock, cachexia and inflammation. Blood Purif. 11:108-117.
6. Chen, Y.-L., V. Le Vraux, J.-P. Giroud, and L. Chauvelot-Moachon. 1994. Anti-tumor necrosis factor properties of non-peptide drugs in acute-phase responses. Eur. J. Pharmacol. 271:319-327.
7. Cusumano, V., et al. Unpublished data.
8. Dinarello, C. A. 1991. Interleukin-1 and interleukin-1 antagonism. Blood 77:1627-1652.
9. Emerson, T. E., Jr., D. C. Lindsey, G. J. Jesmok, M. L. Duerr, and M. A. Fournel. 1992. Efficacy of monoclonal antibody against tumor necrosis factor alpha in an endotoxemic baboon model. Circ. Shock 38:75-84.
10. Espevik, T., and J. Nissen-Meyer. 1986. A highly sensitive cell line, WBH1 164 clone 13, for measuring cytotoxic factor/tumor necrosis factor from human monocytes. J. Immunol. Methods 95:99-105.
11. Godtfredsen, W. O., S. Jahnsen, H. Lorck, K. Roholt, and L. Tybring. 1962. Fusidic acid: a new antibiotic. Nature (London) 193:987.
12. Heinzel, F. P. 1990. The role of IFN-gamma in the pathology of experimental endotoxemia. J. Immunol. 145:2920-2924.
13. Jarvis, W. R. 1987. Epidemiology of nosocomial infections in pediatric patients. Pediatr. Infect. Dis. J. 6:344-351.
14. Jesmok, G., C. Lindsey, M. Duerr, M. Fournel, and T. Emerson, Jr. 1992. Efficacy of monoclonal antibody against human recombinant tumor necrosis factor in E. coli-challenged swine. Am. J. Pathol. 141:1197-1207.
15. Leonard, E. M., H. K. van Saene, P. Shears, J. Walker, and P. K. Tam. 1990. Pathogenesis of colonization and infection in a neonatal surgical unit. Crit. Care Med. 18:264-269.
16. Lynn, W. A., and J. Cohen. 1995. Adjunctive therapy for septic shock: a review of experimental approaches. Clin. Infect. Dis. 20:143-158.
17. Mancuso, G., V. Cusumano, J. A. Cook, E. Smith, F. Squadrito, G. Blandino, and G. Teti. 1994. Efficacy of tumor necrosis factor alpha and eicosanoid inhibitors in experimental models of neonatal sepsis. FEMS Immunol. Med. Microbiol. 9:49-54.
18. Mancuso, G., F. Tomasello, M. Migliardo, D. Delfino, J. Cochran, J. A. Cook, and G. Teti. 1994. Beneficial effects of interleukin-6 in neonatal mouse models of group B streptococcal disease. Infect. Immun. 62:4997-5002.
19. Morrison, D. C., and J. L. Ryan. 1987. Endotoxins and disease mechanisms. Annu. Rev. Med. 38:417-432.
20. Natanson, C. W. D. Hoffman, A. F. Suffredini, P. Q. Eichacker, and R. L. Danner. 1994. Selected treatment strategies for septic shuck based on proposed mechanisms of pathogenesis. Ann. Intern. Med. 120:771-783
21. Nicoletti, F., R. Di Marco, S. Morrone, P. Zaccone, D. Lembo, S. Grasso, A. Santoni, P. L. Meroni, and K. Bendtzen. 1994. Reduction of spontaneous autoimmune diabetes in diabetes-prone BB rats with the novel immunosuppressant fusidic aicid. Effect on T-cell proliferation and production of interferon-gamma. Immunology 81:317-321.
22. Nicoletti, F., P. L. Meroni, M. Lunetta, R. Vigo, T. Palermo, D. Papalia, W. Barcellini, M. Di Mauro, M. Caruso-Nicoletti, L. Mughini, and C. Zanussi. 1991. Sodium fusidate and increased remission rate of insulin-dependent diabetes mellitus. Lancet 337:1292.
23. Nicoletti, F., P. Zaccone, R. Di Marco, G. Magro, S. Grasso, S. Morrone, A. Santoni, G. Tempera, P. L. Meroni, and K. Bendtzen. 1995. Effects of sodium fusidate in animal models of insulin-dependent diabetes mellitus and septic shock. Immunology 85:645-650.
24. Reeves, D. S. 1987. The pharmacokinetics of fusidic acid. J. Antimicrob. Chemother. 20:467-476.
25. Teti, G., G. Mancuso, and F. Tomasello. 1993. Cytokine apperance and effects of anti-tumor necrosis factor alpha antibodies in a neonatal rat model of group B streptococcal infection. Infect. Immun. 61:227-235.
26. Tracey, K. J., Y. Fong, D. G. Hesse, K. R. Manogue, A. T. Lee, G. C. Kuo, S. F. Lowry, and A. Cerami. 1487. Anti-cachectin/TNF monoclonal antibodies prevent septic shock during lethal bacteraemia. Nature (London) 330: 662-664.
27. Verhoef, J., and E. Mattsson. 1995. The role of cytokines in gram-positive bacterial shock. Trends Microbiol. 3:136-140.
28. von Daehne, W., W. O. Godtfredsen, and P. R. Rasmussen. 1979. Structure-activity relationships in fusidic acid-type antibiotics. Adv. Appl. Microbiol. 25:45-146.
29. Zeller, W. P., M. Goto, L. Witek-Janusek, and R. M. Hurley. 1991. Mortality, temporal substrate and insulin responses to endotoxie shock in zero, ten and twenty-eight day old rats. Surg. Gynecol. Obstet. 173:375-383.